Chemoinformaics analysis of 1-Phenyl-1,2-propanedione
| Molecular Weight | 148.161 | nRot | 2 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 8 |
| Exact Molecular Weight | 148.052 | nRing | 1 |
| Solubility: LogS | -1.617 | nHRing | 0 |
| Solubility: LogP | 1.305 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 21.9683 |
| nHD | 0 | BPOL | 9.76166 |
| QED | 0.47 |
| Synth | 1.617 |
| Natural Product Likeliness | 0.063 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.01 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.318 |
| MDCK | 0.000025 |
| BBB | 0.372 |
| PPB | 0.866928 |
| VDSS | 0.333 |
| FU | 0.0795258 |
| CYP1A2-inh | 0.963 |
| CYP1A2-sub | 0.59 |
| CYP2c19-inh | 0.517 |
| CYP2c19-sub | 0.141 |
| CYP2c9-inh | 0.19 |
| CYP2c9-sub | 0.36 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.196 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.236 |
| CL | 3.644 |
| T12 | 0.642 |
| hERG | 0.048 |
| Ames | 0.197 |
| ROA | 0.032 |
| SkinSen | 0.844 |
| Carcinogencity | 0.364 |
| EI | 0.994 |
| Respiratory | 0.661 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.847112 |